Company profile for ADMA Biologics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us, and our hands-on approach to production and development that sets us apart. Our goal is to be a leader in developing and commercializing specialized, targeted, plasma-derived therapeutics to extend and enhance the ...
ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us, and our hands-on approach to production and development that sets us apart. Our goal is to be a leader in developing and commercializing specialized, targeted, plasma-derived therapeutics to extend and enhance the lives of individuals who are naturally or medically immunocompromised.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
465 Route 17 South Ramsey, NJ 07446
Telephone
Telephone
201 478 5552
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/05/3181938/33130/en/ADMA-Biologics-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/10/29/3176289/33130/en/ADMA-Biologics-to-Report-Third-Quarter-2025-Financial-Results-on-November-5-2025.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/08/06/3128654/33130/en/ADMA-Biologics-Announces-Second-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
06 Aug 2025

https://www.globenewswire.com/news-release/2025/07/30/3123900/33130/en/ADMA-Biologics-to-Report-Second-Quarter-2025-Financial-Results-on-August-6-2025.html

GLOBENEWSWIRE
30 Jul 2025

https://www.globenewswire.com/news-release/2025/05/07/3076554/33130/en/ADMA-Biologics-Announces-First-Quarter-2025-Financial-Results-and-Provides-Business-Update.html

GLOBENEWSWIRE
07 May 2025

https://www.globenewswire.com/news-release/2025/04/30/3071179/33130/en/ADMA-Biologics-to-Report-First-Quarter-2025-Financial-Results-on-May-7-2025.html

GLOBENEWSWIRE
30 Apr 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty